CSIMarket
 
Checkmate Pharmaceuticals Inc   (NASDAQ: CMPI)
 

Checkmate Pharmaceuticals Inc's Suppliers Performance

CMPI's Supply Chain




 
CMPI Costs vs Sales of Suppliers Growth

• More on CMPI Suppliers






Checkmate Pharmaceuticals Inc's Comment on Supply Chain









CMPI's vs. Suppliers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Checkmate Pharmaceuticals Inc 227.12 0.00 -63.14 -
Veeva Systems Inc 50,433.17 3,456.71 1,014.77 7,928
Alimera Sciences Inc 301.29 98.09 -14.70 159
Coherus Oncology inc 99.22 50.94 -132.13 147
Catalent Inc 11,553.36 4,422.00 -413.00 16,900
Heron Therapeutics Inc 71.20 151.51 -34.05 128
SUBTOTAL 138,086.00 18,395.87 -1,745.74 52,590
7 more Suppliers available

Sign in to see all suppliers for Checkmate Pharmaceuticals Inc .



Sources: Checkmate Pharmaceuticals Inc 's official press releases and regulatory filings; CSIMarket.com's supply-chain research; and the financial filings and press releases of other companies cited in this report.
Updated on:
For your research, we’ve provided nine additional tables on Checkmate Pharmaceuticals Inc ’s suppliers.
You can find them in the navigation menu under Suppliers.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.